Iodide

Iodide

SCHEMBL1502860

CCc1ccccc1C(N)(CC)CC.I

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.41
GABRB2 P47870 3/20 0.41
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MGLL Q99685 1/20 0.34
IDO1 P14902 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PNMT P11086 1/20 0.31
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643737 0.98 GABRA1 (0.43) GABRA1GABRB2MAPTALDH1A1MGLL
Water SCHEMBL187638 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Benzene SCHEMBL29130110 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Bromide SCHEMBL637596 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Fluoride SCHEMBL1502835 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Hydrazine SCHEMBL10865940 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Water SCHEMBL1973854 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Hydrochloric Acid SCHEMBL77688 0.96 GABRA1 (0.41) GABRA1GABRB2MAPTALDH1A1MGLL
Cyanide SCHEMBL4048234 0.94 GABRA1 (0.40) GABRA1GABRB2MAPTALDH1A1MGLL
Alcohol SCHEMBL28273112 0.90 GABRA1 (0.42) GABRA1GABRB2MAPTALDH1A1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113087625-B Method for synthesizing benzyl acetate by utilizing combined catalytic system 潜江新亿宏有机化工有限公司 2022-04-01 CN claimed
CN-113087625-A Method for synthesizing benzyl acetate by utilizing combined catalytic system 潜江新亿宏有机化工有限公司 2021-07-09 CN claimed
CN-109384813-A A kind of preparation method of tenofovir disoproxil fumarate analog 广州白云山医药集团股份有限公司白云山制药总厂 2019-02-26 CN claimed
US-7812109-B2 Resins based on ketones and aldehydes, having improved solubility properties and low color numbers EVONIK DEGUSSA GMBH (DE) 2010-10-12 US claimed
US-20090105442-A1 RESINS BASED ON KETONES AND ALDEHYDES, HAVING IMPROVED SOLUBILITY PROPERTIES AND LOW COLOR NUMBERS EVONIK DEGUSSA GMBH (DE) 2009-04-23 US claimed
US-7101958-B2 Ketone-aldehyde resins having low water content, high thermal stability and yellowing resistance DEGUSSA AG (DE) 2006-09-05 US claimed
US-20060074217-A1 Ketone-aldehyde resins having low water content, high thermal stability and yellowing resistance DEGUSSA AG (DE) 2006-04-06 US claimed
US-20050010016-A1 Resins based on ketones and aldehydes, having improved solubility properties and low color numbers DEGUSSA AG (DE) 2005-01-13 US claimed
EP-0249125-B1 PROCESS FOR THE PRODUCTION OF AN ELECTRICALLY CONDUCTIVE SURFACE LAYER ON MOULDED PLASTIC ARTICLES BASF Aktiengesellschaft (DE) 1991-10-16 EP claimed
US-4293702-A FROM 2-ALKOXYBENZOTHIAZOLES; CATALYST OF TERTIARY AMINE, QUATERNARY AMMONIUM COMPOUND OR DIALKYL SULFATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-10-06 US claimed
US-4012428-A Method for preparing 3-methyl-2-(4-halogenophenyl)-butyronitrile SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-03-15 US claimed
US-20250368676-A1 PROCESS FOR PREPARING NAMODENOSON ACCELLIENT PARTNERS LLC 2025-12-04 US disclosed
CN-115380023-B Polyhydroxy resin, epoxy resin, method for producing same, epoxy resin composition using same, and cured product 日铁化学材料株式会社 2025-04-11 CN disclosed
CN-119613702-A Silica powder dispersing agent modified based on natural phenolic compounds and preparation method thereof 常熟耐素生物材料科技有限公司 2025-03-14 CN disclosed
CN-119161272-A Polyhydroxy resin, epoxy resin, method for producing same, epoxy resin composition using same, and cured product 日铁化学材料株式会社 2024-12-20 CN disclosed
US-4414254-A WINDOW HAVING URETHANE LINKAGES IN THE INTERFACE OF LAMINATE PROTECTIVE LAYER TEIJIN LIMITED (JP) 1983-11-08 US disclosed
EP-0057330-A1 Selective light-transmitting laminate TEIJIN LIMITED (JP) 1982-08-11 EP disclosed
US-4293702-A FROM 2-ALKOXYBENZOTHIAZOLES; CATALYST OF TERTIARY AMINE, QUATERNARY AMMONIUM COMPOUND OR DIALKYL SULFATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-10-06 US disclosed
US-4113970-A REACTING 1,3-BUTADIENE WITH CARBOXYLIC ACID; PALLADIUM, IODINE-CONTAINING CATALYST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1978-09-12 US disclosed
US-4012428-A Method for preparing 3-methyl-2-(4-halogenophenyl)-butyronitrile SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368676-A1 PROCESS FOR PREPARING NAMODENOSON NAMPT, NQO1, AMPD1 GABRA1 3016/4885GABRB2 3770/4885MAPT 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.